Intelomed
Pittsburgh, US · Delaware corporation
Find your way into Intelomed
Sign up to see every warm intro you have to Intelomed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intelomed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JB
Jan BerkowFounder
MD
Michael DignazioExecutive
JF
Jill F. SchiaparelliExecutive
FJ
Frank J AmorusoExecutive
Board
MR
Mark RossiBoard director
MB
MaryDel BradyBoard director
RS
R. Stephen DoyleBoard director
WP
William P. MalloyBoard director
MD
Mary Del BradyBoard director
JS
James SweeneyBoard director
JM
John MoranBoard director
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 3 rounds · 2014–2016
▶$502.4KraisedJan 2017 · 10 investors · BiotechnologyRule 506(b)
▶$502.4KraisedJan 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jill F. SchiaparelliExecutive Officer, Director
- William P. MalloyDirector
- Ned LaubacherDirector
- Michael DignazioExecutive Officer
- Mark RossiDirector
- R. Stephen DoyleDirector
- Offering amount
- $1.5M
- Amount sold
- $502.4K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedJan 2016 · 8 investors · BiotechnologyRule 506(b)
▶$1.9MraisedJan 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark RossiDirector
- R. Stephen DoyleDirector
- William P. MalloyDirector
- Michael DignazioExecutive Officer
- Mary Del BradyDirector
- Jill F. SchiaparelliExecutive Officer, Director
- Jan BerkowExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $10K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedJul 2014 · 29 investors · BiotechnologyRule 506(b)
▶$3.8MraisedJul 2014 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James SweeneyDirector
- MaryDel BradyDirector
- John MoranDirector
- Jan BerkowDirector, Promoter
- William P. MalloyDirector
- Mark RossiDirector
- Frank J AmorusoExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- Minimum investment
- $25.2K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| NASA | Phase I | 2019 | $119.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Intelomed?
- Intelomed was founded by Jan Berkow.
- How much funding has Intelomed raised?
- Intelomed has disclosed $6.2M raised across 3 rounds.
- Where is Intelomed headquartered?
- Intelomed is headquartered in Pittsburgh, US.